157 related articles for article (PubMed ID: 10190728)
41. Profile of von Willebrand factor antigen and von Willebrand factor propeptide in an overall TIA and ischaemic stroke population and amongst subtypes.
Tobin WO; Kinsella JA; Kavanagh GF; O'Donnell JS; McGrath RT; Tierney S; Egan B; Feeley TM; Coughlan T; Collins DR; O'Neill D; Murphy S; Lim SJ; Murphy RP; McCabe D
J Neurol Sci; 2017 Apr; 375():404-410. PubMed ID: 28320178
[TBL] [Abstract][Full Text] [Related]
42. Effects of increased von Willebrand factor levels on primary hemostasis in thrombocytopenic patients with liver cirrhosis.
Wannhoff A; Müller OJ; Friedrich K; Rupp C; Klöters-Plachky P; Leopold Y; Brune M; Senner M; Weiss KH; Stremmel W; Schemmer P; Katus HA; Gotthardt DN
PLoS One; 2014; 9(11):e112583. PubMed ID: 25397410
[TBL] [Abstract][Full Text] [Related]
43. Endothelial dysfunction marker von Willebrand factor antigen in haemodialysis patients: associations with pre-dialysis blood pressure and the acute phase response.
Borawski J; Naumnik B; Pawlak K; Mysliwiec M
Nephrol Dial Transplant; 2001 Jul; 16(7):1442-7. PubMed ID: 11427638
[TBL] [Abstract][Full Text] [Related]
44. Short-term high-dose folic acid does not alter markers of endothelial cell damage in patients with coronary heart disease.
Doshi SN; Moat SJ; Lewis MJ; McDowell IF; Giddings JC; Goodfellow J
Int J Cardiol; 2004 Apr; 94(2-3):203-7. PubMed ID: 15093982
[TBL] [Abstract][Full Text] [Related]
45. Endothelial activation, dysfunction, and damage in congestive heart failure and the relation to brain natriuretic peptide and outcomes.
Chong AY; Freestone B; Patel J; Lim HS; Hughes E; Blann AD; Lip GY
Am J Cardiol; 2006 Mar; 97(5):671-5. PubMed ID: 16490435
[TBL] [Abstract][Full Text] [Related]
46. Progressive endothelial damage revealed by multilevel von Willebrand factor plasma concentrations in atrial fibrillation patients.
Scridon A; Girerd N; Rugeri L; Nonin-Babary E; Chevalier P
Europace; 2013 Nov; 15(11):1562-6. PubMed ID: 23689486
[TBL] [Abstract][Full Text] [Related]
47. Markers of endothelial function in pediatric stem cell transplantation for acute leukemia.
Luzzatto G; Cella G; Messina C; Randi ML; Sbarai A; Zanesco L
Med Pediatr Oncol; 2003 Jan; 40(1):9-12. PubMed ID: 12426679
[TBL] [Abstract][Full Text] [Related]
48. Nitric oxide and renal functions in liver cirrhosis.
Türkay C; Yönem O; Arikan O; Baskin E
Turk J Gastroenterol; 2004 Jun; 15(2):73-6. PubMed ID: 15334313
[TBL] [Abstract][Full Text] [Related]
49. von Willebrand factor: a marker of endothelial dysfunction in vascular disorders?
Lip GY; Blann A
Cardiovasc Res; 1997 May; 34(2):255-65. PubMed ID: 9205537
[TBL] [Abstract][Full Text] [Related]
50. Endothelin and von Willebrand factor as parameters of endothelial function in idiopathic dilated cardiomyopathy: different stimuli for release before and after heart transplantation?
Galatius S; Wroblewski H; Sørensen VB; Bie P; Parving HH; Kastrup J
Am Heart J; 1999 Mar; 137(3):549-54. PubMed ID: 10047640
[TBL] [Abstract][Full Text] [Related]
51. Significance of increased plasma adrenomedullin concentration in patients with cirrhosis.
Kojima H; Tsujimoto T; Uemura M; Takaya A; Okamoto S; Ueda S; Nishio K; Miyamoto S; Kubo A; Minamino N; Kangawa K; Matsuo H; Fukui H
J Hepatol; 1998 May; 28(5):840-6. PubMed ID: 9625320
[TBL] [Abstract][Full Text] [Related]
52. Increased plasma levels of immunoreactive endothelin and von Willebrand factor in NIDDM patients.
Morise T; Takeuchi Y; Kawano M; Koni I; Takeda R
Diabetes Care; 1995 Jan; 18(1):87-9. PubMed ID: 7698054
[TBL] [Abstract][Full Text] [Related]
53. [Platelet activation and endothelial factors in standard exercise test before and after menopause].
Krzysiek J; Milewicz T; Dybkowski R; Janczak-Saif A; Dembińska-Kieć A; Anna AZ; Guevara I; Sztefko K; Radowicki S; Dubiel JS; Klimek R
Przegl Lek; 2001; 58(5):419-25. PubMed ID: 11603175
[TBL] [Abstract][Full Text] [Related]
54. Endothelial function in patients with newly diagnosed type 2 diabetes receiving early intensive insulin therapy.
Tian J; Wang J; Li Y; Villarreal D; Carhart R; Dong Y; Wen Y; Liu K
Am J Hypertens; 2012 Dec; 25(12):1242-8. PubMed ID: 22895449
[TBL] [Abstract][Full Text] [Related]
55. Significant Association between Serum Levels of Von Willebrand Factor (vWF) Antigen with Stages of Cirrhosis.
Yilmaz VT; Dincer D; Avci AB; Cetinkaya R
Eurasian J Med; 2015 Feb; 47(1):21-5. PubMed ID: 25745341
[TBL] [Abstract][Full Text] [Related]
56. von Willebrand factor and its relevance to cardiovascular disorders.
Lip GY; Blann AD
Br Heart J; 1995 Dec; 74(6):580-3. PubMed ID: 8541159
[TBL] [Abstract][Full Text] [Related]
57. Von Willebrand Factor as a new marker for non-invasive assessment of liver fibrosis and cirrhosis in patients with chronic hepatitis C.
Maieron A; Salzl P; Peck-Radosavljevic M; Trauner M; Hametner S; Schöfl R; Ferenci P; Ferlitsch M
Aliment Pharmacol Ther; 2014 Feb; 39(3):331-8. PubMed ID: 24308724
[TBL] [Abstract][Full Text] [Related]
58. New insights into the non-hemostatic role of von Willebrand factor in endothelial protection.
Agostini S; Lionetti V
Can J Physiol Pharmacol; 2017 Oct; 95(10):1183-1189. PubMed ID: 28715643
[TBL] [Abstract][Full Text] [Related]
59. Anti-oxidative properties of beta-blockers and angiotensin-converting enzyme inhibitors in congestive heart failure.
Chin BS; Langford NJ; Nuttall SL; Gibbs CR; Blann AD; Lip GY
Eur J Heart Fail; 2003 Mar; 5(2):171-4. PubMed ID: 12644008
[TBL] [Abstract][Full Text] [Related]
60. Gut-derived endotoxin stimulates factor VIII secretion from endothelial cells. Implications for hypercoagulability in cirrhosis.
Carnevale R; Raparelli V; Nocella C; Bartimoccia S; Novo M; Severino A; De Falco E; Cammisotto V; Pasquale C; Crescioli C; Scavalli AS; Riggio O; Basili S; Violi F
J Hepatol; 2017 Nov; 67(5):950-956. PubMed ID: 28716745
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
